Voya Small Cap Growth Strategy Quarterly Commentary - 4Q22

Voya Small Cap Growth Strategy Quarterly Commentary - 4Q22

Focusing on High-Quality Companies with Sustainable Growth Trends

Voya Small Cap Growth Strategy Quarterly Commentary - 4Q22

Actively managed small cap growth strategy driven by bottom-up fundamental research seeking high-quality companies with strong balance sheets and cash flow characteristics that are beneficiaries of sustainable growth trends.

Key Takeaways

  • Fourth quarter returns for small cap growth stocks, as measured by the Russell 2000 Growth index, were positive, albeit a bit of a bumpy ride.
  • October and November saw nice upside resulting from evidence that US Federal Reserve policy was starting to take hold and perhaps the continuous cycle of rate hikes would subside. December proved more challenging, as inflation and recessionary fears reared their ugly heads and continued to weigh heavily on investors’ minds.
  • From conversations with management teams, there is evidence of a slowing economy, as Fed policy implemented in 2022 will affect economic growth in the year ahead.

Portfolio Review

For the quarter ended December 31, 2022, the strategy outperformed the index, due to individual stock selection. The consumer discretionary, energy and financials sectors added the most to performance. Sector allocation was a slight detractor along with stock selection in the information technology sector.

Key contributors to performance included Helix Energy Solutions Group, Inc., Axon Enterprises, Inc. and Planet Fitness, Inc.

Helix Energy Solutions Group, Inc. (HLX), an offshore energy services company, was the largest positive contributor for the quarter. On the heels of a solid 3Q22 beat and raise resulting from increased order flow, Helix continues to see improving fundamentals. Although 2023 will see significant financial performance improvements, the earnings revisions higher will likely be more muted and thus we have started to trim the position after significant outperformance.

Axon Enterprises, Inc. (AXON), a manufacturer of personal defense systems for law enforcement agencies, outperformed during the quarter after reporting 3Q22 upside and raising forward guidance. Domestic and international public defense spending is an area of resilience, which we expect to continue. Axon remains a top holding and we are encouraged by the forward growth prospects.

Planet Fitness, Inc. (PLNT), an operator and franchiser of fitness centers, saw continued membership growth and the reset of unit growth expectations for 2023 due to HVAC supply chain issues was received well by investors. The stock struggled earlier in the year, as a result of these same unit growth concerns. With 2022- and 2023-unit growth expectations reset, we added to our position during the fourth quarter and the stock outperformed.

Key detractors from performance included R1 RCM Inc., Chart Industries, Inc. and Pacira Biosciences, Inc.

R1 RCM Inc. (RCM), a provider of revenue cycle management services to the healthcare industry, was the largest detractor for the quarter. RCM struggled with a key new customer implementation and an elongated payment collection cycle during the quarter. In addition, they guided down for 2023, sighting a 10–15% reduction in earnings before interest, taxes, depreciation and amortization (EBITDA). Following this news, we trimmed our position based on an unexpected fundamental change.

Chart Industries, Inc. (GTLS), a manufacturer of engineered equipment utilized in the infrastructure of the industrial gas and energy industries, struggled during the quarter. In the weeks following a positive 3Q22 earnings report, management announced a $4 billion strategic acquisition of United Kingdom based Howden Group, a maker of air and gas handling products. Investors grew concerned that GTLS was paying a premium multiple for peak fundamentals going into a recession, which caused a dramatic selloff in the stock. To compound investor angst, the company raised $3.5 billion of debt at rates ranging from 7.5% and 9.5% to fund the acquisition, which will burden GTLS with Debt/EBITDA for 2024 of 5x or more. After considering the higher debt burden and slower growth for the combined company, we trimmed the positions.

Pacira Biosciences, Inc. underperformed due to weak sales of its main product Exparel, an opioid sparing product used by surgeons to alleviate pain at the surgery site for up to 72 hours. Despite providing longer relief than the generic alternative, Exparel’s cost per dose is much greater. As hospitals and surgery centers deal with increased labor costs resulting from staffing shortages, the demand for Exparel has tempered meaningfully as procedure volumes continue to languish. We expect Exparel sales for 4Q22 to be down from 4Q21 and believe the 2023 consensus number of $603m in sales needs to be adjusted down. We trimmed our position during the quarter and will look for evidence that demand is accelerating.

Current Strategy and Outlook

Investors can be forgiven for wanting to put 2022 in the rearview mirror. High inflation, rate hikes, market volatility, the war in Ukraine and resurging Covid infections top the list of things we would like to move past. Will 2023 bring more troubles, or do investors have reasons for optimism? The Eurozone appears to be headed for a recession, whereas the United States seems slightly less at risk. The markets are hunting for imbalances, such as whether China’s return to growth will be stymied by its significant debt burden. There is at least one reason for optimism: The end of the global interest-rate hiking cycle may be in sight, letting markets focus more on economic fundamental factors.


Effective January 1, 2022, Voya Investment Management acquired the investment advisory business and certain other assets of Tygh Capital Management (TCM). As such, AUM, performance and characteristics prior to 12/31/21 pre-date the acquisition and are reflective of the strategy as managed by TCM.

The Russell 2000 Growth Index is an unmanaged index that measures the performance of securities of smaller U.S. companies with greater-than-average growth orientation. The Index does not reflect fees, brokerage commissions, taxes or other expenses of investing. Investors cannot invest directly in an index.

Principal Risks: All investing involves risks of fluctuating prices and the uncertainties of rates of return and yield. In exchange for higher growth potential, investing in stocks of Smaller Companies may entail greater price volatility and less liquidity than investing in stocks of larger companies. Other risks of the Portfolio include but are not limited to: Growth Investing Risks, Market Trends Risks, Other Investment Companies’ Risks, Price Volatility Risks, Liquidity Risks, Portfolio Turnover Risks and Securities Lending Risks. Investors should consult the Portfolio’s Prospectus and Statement of Additional Information for a more detailed discussion of the Portfolio’s risks. An investment in the Portfolio is not a bank deposit and is not insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.

The strategy employs a quantitative model to execute the strategy. Data imprecision, software or other technology malfunctions, programming inaccuracies and similar circumstances may impair the performance of these systems, which may negatively affect performance. Furthermore, there can be no assurance that the quantitative models used in managing the strategy will perform as anticipated or enable the strategy to achieve its objective.

The strategy is available as a mutual fund or variable portfolio. The mutual fund may be available to you as part of your employer sponsored retirement plan. There may be additional plan level fees resulting in personal performance that varies from stated performance. Please call your benefits office for more information.

Variable annuities and group annuities are long-term investments designed for retirement purposes. If withdrawals are taken prior to age 59½, an IRS 10% premature distribution penalty tax may apply. Money taken from the annuity will be taxed as ordinary income in the year the money is distributed. An annuity does not provide any additional tax deferral benefit, as tax deferral is provided by the plan. Annuities may be subject to additional fees and expenses to which other tax-qualified funding vehicles may not be subject. However, an annuity does provide other features and benefits, such as lifetime income payments and death benefits, which may be valuable to you.

Variable investments, of any kind, are not guaranteed and are subject to investment risk including the possible loss of principal. The investment return and principal value of the security will fluctuate so that when redeemed, it may be worth more or less than the original investment. In addition, there is no guarantee that any variable investment option will meet its stated objective. All guarantees are based on the financial strength and claims paying ability of the issuing insurance company, who is solely responsible for all obligations under its policies.

Insurance products, annuities and funding agreements issued by Voya Retirement Insurance and Annuity Company (“VRIAC”), One Orange Way, Windsor, CT 06095, which is solely responsible for meeting its obligations. Plan administrative services provided by VRIAC or Voya Institutional Plan Services, LLC (“VIPS”). Securities distributed by or offered through Voya Financial Partners, LLC (“VFP”) (member SIPC)or other broker-dealers with which it has a selling agreement. Only Voya Retirement Insurance and Annuity Company is admitted and can issue products in the state of New York. All companies are members of Voya Financial.

This commentary has been prepared by Voya Investment Management for informational purposes. Nothing contained herein should be construed as (i) an offer to sell or solicitation of an offer to buy any security or (ii) a recommendation as to the advisability of investing in, purchasing or selling any security. Any opinions expressed herein reflect our judgment and are subject to change. Certain of the statements contained herein are statements of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Actual results, performance or events may differ materially from those in such statements due to, without limitation, (1) general economic conditions, (2) performance of financial markets, (3) interest rate levels, (4) increasing levels of loan defaults (5) changes in laws and regulations and (6) changes in the policies of governments and/or regulatory authorities. Past performance is no guarantee of future results.

The opinions, views and information expressed in this commentary regarding holdings are subject to change without notice. The information provided regarding holdings is not a recommendation to buy or sell any security. Portfolio holdings are fluid and are subject to daily change based on market conditions and other factors.